Bioconjugates, ADCs & Chemistry - Abzena

Leading Biologics, Bioconjugates & ADC CDMO

Specialized complex biologics, bioconjugate and antibody-drug conjugate (ADC) development and manufacturing services.

Why Abzena? Download Brochure

For over 20 years Abzena has provided integrated, end-to-end solutions and services that accelerate biologics, bioconjugate, and ADC development and ADC manufacturing. Our unique approach helps make us far more than a traditional Contract Development & Manufacturing Organization (CDMO).

Contact Us

The Leading Biologic and Bioconjugate CDMO + CRO

Taking the decision to work with a biologics CDMO partner is challenging, and amongst the most crucial early decisions you will make on your molecule’s development. Abzena are ready to work together with you to de-risk and streamline the development and manufacture of your novel treatments such as ADCs, AOCs and RDCs so that you can rapidly bridge from discovery through commercial launch.

Contact Us

Why Abzena?

We offer a uniquely collaborative, personalized, and transparent partnership differentiated by our mission to keep moving medicine forward and our values. Leverage the insights gained from over 20 years of experience, and multiple decades of scientific knowledge across our team today.

We offer best-in-class biologics, bioconjugates and ADC CDMO + CRO services along with a highly detailed and personalized experience. Contact us today to find out more about our expanding ADC capabilities.

Contact Us

Extensive R&D capabilities with over 20 years of biologics, bioconjugates, & ADC CDMO experience

From biologics design to ADC developability, through to commercial manufacturing, Abzena offer integrated contract research, development, and manufacturing services for many of the leading pharma and biotech customers. Our scientific experts at our locations in Cambridge UK, Bristol and San Diego USA have experience working with hundreds of molecules across all stages of the drug development process.

Our Locations

ThioBridge®: Antibody Drug Conjugation (ADC) Platform Technology

Enhance your ADC development with our ThioBridge™ conjugation platform technology. ThioBridge™ has been developed to overcome many of the issues seen in existing technologies. It gives our customers ADCs improved stability, potency, and efficacy.

Explore ThioBridge®

Bioconjugation Offering

ADC & Bioconjugation Services

Abzena has over 20 years of expertise in identifying and mapping the appropriate design space for the development of your complex antibody-drug conjugates (ADCs).

Through our developability assessments, we identify and de-risk your clinical candidates for development, ensuring that your timescales are met.

Bioconjugates & ADC Services
Bioconjugate & ADC Design Bioconjugate & ADC Development Linker Payload Process Development & Optimization cGMP Bioconjugate & ADC Manufacturing Antibody Drug Conjugate Manufacturing Analytical Method Development & Validation

Latest ADC News & Insights

News

Abzena Announces Major Investment in Bioconjugation and ADC Capabilities

Read More

News

Abzena & Argonaut Partner to Offer Accelerated End-to-End Drug Development Support

Read More

Articles

Abzena Recognized as Top CDMO in 2024 by Pharma Tech Outlook

Read More